Anzeige
Mehr »
Login
Dienstag, 16.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Biotech-Perle kurz vor entscheidender Meilenstein-Meldung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

AFX News-Archiv vom 10.09.2017

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
10.09.17US: Trump Signs Aid Package To Harvey's Victims260WASHINGTON (dpa-AFX) - U.S. President Donald Trump signed a US$ 15.25 billion relief package to victims of the Hurricane Harvey, which includes raising the government debt ceiling, according...
► Artikel lesen
10.09.17ARGENTINA: Europe Will Resume Argentinean Biodiesel Imports104BUENOS AIRES (dpa-AFX) - After a four-year absence, the European Union (EU) will reopen to Argentinean biodiesel imports. According to the Argentinean Foreign Ministry, biodiesel sales to...
► Artikel lesen
10.09.17Simply Fresh Foods Recalls 'San Francisco Seafood Salad' Due To Undeclared Milk93WASHINGTON (dpa-AFX) - Simply Fresh Foods, Inc. of Buena Park, CA is recalling 272 cases of one specific lot of its 4-4 ounce packages of 'San Francisco Seafood Salad Made with Greek Yogurt'...
► Artikel lesen
10.09.17Garden Of Life LLC Recalls Baby Organic Liquid Formula203WASHINGTON (dpa-AFX) - The Palm Beach Gardens, Fla.-based Garden of Life, LLC, announced precautionary recall of its new supplement for infants, Baby Organic Liquid, because the product may...
► Artikel lesen
10.09.17Michigan-based Northside Noodle Recalls Meatball Products96WASHINGTON (dpa-AFX) - The U.S. Department of Agriculture's Food Safety and Inspection Service (FSIS) announced that Northside Noodle Co., an Iron Mountain, Michigan, establishment, is recalling...
► Artikel lesen
10.09.17Novartis: New Data Confirm Lucentis Efficacy And Durability Vs Aflibercept175BASEL (dpa-AFX) - Novartis (NVS) announced that one-year interim results from the Phase IV head-to-head RIVAL study comparing Lucentis (ranibizumab) versus aflibercept confirm strong efficacy...
► Artikel lesen